SEC Filing Analysis: SANGAMO THERAPEUTICS, INC (SGMO)

Executive Summary

• Trading Significance: Low
• Key Takeaway: The President & CEO, Sandy Macrae, disposed of 126,950 shares in a non-discretionary transaction to cover tax obligations related to vested Restricted Stock Units (RSUs).
• Market Impact: Neutral. This is a routine, mandatory transaction with negligible financial impact and does not signal a change in insider sentiment.

Company Information

Field	Value
Company	SANGAMO THERAPEUTICS, INC
Ticker Symbol	SGMO
CIK	0001001233
Industry	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

Field	Value
Name	Macrae Sandy
CIK	0001675687
Title/Position	PRESIDENT, CEO AND DIRECTOR
Relationship	Director, Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-10-22
Transaction Code	F - Payment of tax liability by withholding securities
Security Type	Common Stock
Shares Involved	126,950
Price Per Share	$0.66
Total Value	$83,787
Shares Owned After	2,057,022
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$83,787
% of Market Cap	0.044%
Shares Transacted	126,950
% of Shares Outstanding	0.042%
Post-Transaction Ownership	2,057,022 shares (0.68% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a company with a market capitalization of $190 million, this $83,787 transaction is financially immaterial.
• Ownership Concentration: The CEO's post-transaction ownership of over 2 million shares, representing 0.68% of shares outstanding, shows continued significant alignment with shareholder interests despite this minor disposition.
• Dilution Impact: Not applicable as this is a disposition of shares, not an issuance.
• Transaction Significance: The transaction's value is less than 0.1% of the market cap and the shares involved are less than 0.1% of shares outstanding. Combined with its non-discretionary nature, its significance is very low.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The market typically does not react to 'F' code transactions as they are understood to be automatic and necessary for tax purposes, rather than a reflection of the insider's outlook on the company's future performance.

Volume & Sentiment

• Expected Volume Impact: None. The shares were withheld by the issuer and not sold on the open market.
• Sentiment Indicator: Neutral. This transaction does not provide a bullish or bearish signal.

Investment Insights

Positive Market Indicators

• The CEO maintains a substantial holding of over 2 million shares post-transaction.

Risk Factors

• No new risk factors are indicated by this filing.

Key Takeaways

1. Non-Discretionary Sale: This was not a proactive sale by the CEO but a mandatory withholding of shares to cover taxes on vesting RSUs.
2. Immaterial Financial Impact: The transaction size is negligible relative to Sangamo's market cap and total shares outstanding.
3. Continued Insider Alignment: The CEO's remaining stake demonstrates a continued vested interest in the company's success.

Additional Context

Transaction Notes

• Special Circumstances: The filing's footnote explicitly states the shares were surrendered 'solely for mandatory tax withholding purposes' and 'does not represent a discretionary trade by the Reporting Person'.